Every 424B that The Beachbody Company Inc (BODI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BODI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BODI filings page.
The Beachbody Company, Inc. registered for resale up to 543,590 shares of Class A common stock issuable upon exercise of outstanding warrants, for selling shareholders under an existing shelf prospectus. This update incorporates the company’s quarterly results for the period ended June 30, 2026.
For the quarter, Beachbody generated $49.6 million in revenue, down 22% year over year, but produced operating income of $1.7 million and net income of $1.4 million, its fourth consecutive profitable quarter. Gross margin was 72.0%, while operating expenses fell sharply to $34.1 million from $50.2 million. Adjusted EBITDA was $6.7 million, compared with $4.6 million a year earlier.
For the first six months of 2026, revenue declined 24% to $103.9 million, but operating income reached $4.8 million and net income $3.7 million. Cash and cash equivalents were $32.4 million and ABL facility principal remained at $25.0 million. Digital subscriptions were 0.76 million, down from 0.94 million, with strong average digital retention of about 96% and DAU/MAU of roughly 32%.
The Beachbody Company, Inc. filed a prospectus supplement covering the resale, from time to time, of 4,866,405 shares of Class A common stock and 5,333,333 warrants (50 warrants per share, exercisable at $575.00 per share), and the potential issuance of up to 306,667 shares upon exercise of public and private warrants. The supplement incorporates the company’s Form 10-Q for the quarter ended June 30, 2026.
For that quarter, revenue was $49.6 million, down 22% year over year, with gross margin of 72.0%. Operating income was $1.7 million and net income $1.4 million, marking a fourth consecutive profitable quarter, while Adjusted EBITDA reached $6.7 million.
The Beachbody Company, Inc. filed a prospectus supplement covering the resale, from time to time, by selling shareholders of up to 543,590 shares of Class A common stock that may be issued upon exercise of outstanding warrants. The Class A shares trade on Nasdaq under the symbol BODI, and the closing price was $10.94 on August 5, 2026.
Separately, the company entered into Amendment No. 2 to its credit agreement with Tiger Finance, LLC. The amendment revises financial covenants, including lowering the minimum cash threshold that triggers a Covenant Testing Period to $22.5 million, eliminating the billings fixed charge coverage ratio, and setting a minimum liquidity level of $18 million that steps down over time but not below $16 million. The amendment also adjusts operational targets such as minimum digital subscriptions and the Three Month Total Billings Target and sets the interest rate at SOFR plus 9.00% until maturity.
The Beachbody Company, Inc. filed a prospectus supplement covering the resale, from time to time, by selling stockholders of 4,866,405 shares of Class A common stock and 5,333,333 private placement warrants, with every 50 warrants exercisable for one share at $575.00 per share, and the issuance of up to 306,667 shares upon exercise of outstanding public and private warrants.
The company also entered into a second amendment to its credit agreement with Tiger Finance, LLC. Key changes include lowering the minimum cash threshold that triggers covenant testing to $22.5 million, eliminating the billings fixed charge coverage ratio, and setting a minimum liquidity covenant of $18 million, scheduled to decline in monthly steps to $16 million. The Three Month Total Billings Target was increased to 92.5% of forecasted billings and, along with the minimum digital subscriptions covenant (set at 650,000 subscribers through December 31, 2026 and 550,000 thereafter), will only be tested when cash is below $22.5 million. The interest rate on the facility is now SOFR plus 9.00% through maturity, and term loans will amortize at $225,000 per month starting September 1, 2026. As of July 31, 2026, principal outstanding under the amended facility was at least $24,645,834, and the company reported cash of $36.6 million versus $23.6 million of debt on March 31, 2026.
The Beachbody Company, Inc. filed a prospectus supplement registering 543,590 shares of Class A Common Stock for resale by selling shareholders as the shares may be acquired upon exercise of outstanding warrants.
The supplement incorporates a Form 8-K and reports a closing share price of $10.88 on June 3, 2026. The resale relates to securities described as the "Common Warrants" and updates the prospectus dated June 13, 2024.
The Beachbody Company, Inc. is registering 4,866,405 shares of Class A Common Stock, 5,333,333 private placement warrants (every 50 warrants exercisable for one share at an exercise price of $575.00 per share) and 306,667 shares of Class A Common Stock underlying warrants as described in a June 4, 2026 prospectus supplement. The supplement updates the May 22, 2024 prospectus and attaches related Form 8-K information. The company notes a closing sale price of $10.88 per share for Class A Common Stock on June 3, 2026.
The Beachbody Company, Inc. is updating its prospectus supplement to register the resale of 543,590 shares of Class A common stock issuable upon exercise of outstanding warrants, as described in its Form 10-Q for the quarter ended March 31, 2026. The supplement ties the registered resale to the selling shareholders identified in the prospectus and incorporates the quarterly report information filed May 12, 2026.
The Company discloses context from the Form 10-Q including a closing share price of $12.58 per share on May 11, 2026, Class A shares outstanding of 4,512,761 as of May 6, 2026, and the Common Stock Warrants previously issued to institutional investors exercisable at $11.24 per share. The prospectus supplement must be read with the base prospectus.
The Beachbody Company, Inc. registers an aggregate of 4,866,405 shares of Class A common stock and 5,333,333 warrants to purchase Class A common stock, and discloses up to 306,667 shares issuable upon exercise of public and private warrants, offered from time to time by the selling stockholders.
This prospectus supplement dated May 12, 2026 supplements the May 22, 2024 prospectus and incorporates the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. The supplement notes a Class A closing price of $12.58 per share on May 11, 2026.
The Beachbody Company, Inc. files a prospectus supplement registering 543,590 shares of Class A common stock for resale by selling shareholders representing shares issuable upon exercise of outstanding Common Warrants.
The supplement incorporates by reference the Company’s Form 10-K for the fiscal year ended December 31, 2025 and states the March 9, 2026 closing sale price of Class A Common Stock was $8.20. The supplement updates and supplements the Prospectus dated June 13, 2024 and must be read together with that Prospectus.
The Beachbody Company, Inc. filed a prospectus supplement that registers an aggregate of 4,866,405 shares of Class A common stock, 5,333,333 private placement warrants (every 50 warrants exercisable for one share at an exercise price of $575.00) and up to 306,667 shares issuable upon exercise of outstanding public and private warrants. The supplement incorporates the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and updates the original prospectus dated May 22, 2024.
The filing discloses market context: Class A shares outstanding were 4,450,721 and Class X outstanding were 2,729,003 as of March 3, 2026, and the closing sale price per Class A share was $8.20 on March 9, 2026. The supplement ties the registration to the company’s strategic update, including the Pivot from an MLM model to a single-level affiliate model and operating metrics for 2025 (0.9 million digital subscriptions, 0.1 million nutritional subscriptions, DAU/MAU 31.8).
The Beachbody Company filed a prospectus supplement for the resale of up to 543,590 shares of Class A common stock issuable upon exercise of outstanding warrants, updating its base prospectus with its latest Quarterly Report on Form 10‑Q.
For the quarter ended September 30, 2025, revenue was $59.9 million versus $102.2 million a year ago, and net income was $3.6 million versus a loss last year. Year‑to‑date operating cash flow was $16.8 million, and cash and cash equivalents were $33.9 million at quarter‑end. The company has a $35.0 million asset‑based facility with $25.0 million outstanding.
The company disclosed it anticipates violating certain ABL financial covenants at December 31, 2025 and in the first quarter of 2026, which raises substantial doubt about its ability to continue as a going concern within one year after the financial statements are issued; it is in discussions to amend covenants and outlined cost actions. Shares outstanding were 4,359,034 Class A and 2,729,003 Class X as of November 3, 2025.
The Beachbody Company, Inc. filed a Rule 424(b)(3) prospectus supplement covering the resale by selling stockholders of 4,866,405 shares of Class A common stock and 5,333,333 warrants, and the potential issuance of up to 306,667 shares of Class A common stock upon exercise of outstanding public and private placement warrants. Every 50 private placement warrants are exercisable for one share at an exercise price of $575.00 per share.
The supplement attaches the company’s Form 10‑Q for the quarter ended September 30, 2025. Quarterly revenue was $59,887 thousand and net income was $3,569 thousand, with operating income of $4,986 thousand. Cash and cash equivalents were $33,949 thousand and total liabilities were $121,722 thousand.
The 10‑Q discloses anticipated violations of financial covenants under the $35.0 million ABL Facility that raise substantial doubt about the company’s ability to continue as a going concern, although management is in discussions to amend covenants. Shares outstanding were 4,359,034 Class A and 2,729,003 Class X as of November 3, 2025.